Bringing a novel therapy to market is only one of the crucial challenges that universally weigh on Emerging Biopharma companies (EBPs). In tandem with the product lifecycle, between diagnosis and sustained treatment there lies a complex patient journey shaped by reimbursement requirements, affordability barriers, provider confidence, education gaps, and the day-to-day realities patients and caregivers face once therapy begins.

Read the eBook to explore the top priorities for designing patient support strategies that can strengthen performance and build a strong commercial foundation from launch and onward.